Living with Advanced MS? Watch this video to learn more.

Immune globulin intravenous Pregnancy and Breastfeeding Warnings

Immune globulin intravenous is also known as: Bivigam, Carimune, Carimune NF, Flebogamma, Gamimune, Gamimune N 10%, Gamimune N 5%, Gammagard S/D, Gammaplex, Gammar IV, Gammar-P I.V., Gamunex, Iveegam En, Octagam, Panglobulin, Panglobulin NF, Polygam S/D, Privigen, Sandoglobulin, Venoglobulin-S 10%, Venoglobulin-S 5%

Immune globulin intravenous Pregnancy Warnings

Immune globulin intravenous human (IGIV) has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. IGIV has been used successfully during human pregnancy. IGIV is only recommended for use during pregnancy when benefit outweighs risk.

IgG and IgG subclasses have been shown to cross the placenta after 32 weeks of gestation. Placental transfer also appears to be dose and possibly duration dependent. Sacher and colleagues reviewed the clinical indications for IGIV in pregnancy (e.g., hypogammaglobulinemia, immune thrombocytopenic purpura, alloimmune disorders) and recent reports have described the use of IGIV for the prevention of recurrent abortions due to antiphospholipid antibodies, prevention of intracranial hemorrhage in fetal alloimmune thrombocytopenia, neonatal congenital heart block due to maternal antibodies, and severe isoimmunization. No adverse effects have been noted in any of these reports.

Immune globulin intravenous Breastfeeding Warnings

There are no data on the excretion of immune globulin intravenous (human) into human milk.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web4)